
INSP Stock Forecast & Price Target
INSP Analyst Ratings
Bulls say
Inspire Medical Systems is a medical technology company that offers a neurostimulation technology called the Inspire system, which provides a safe and effective treatment for obstructive sleep apnea. Despite facing challenges in the past with a volatile reimbursement environment, the company has shown signs of improvement, with 2Q26 results exceeding expectations. Upcoming potential catalysts, such as the CPTEditorial Panel, final CMS codes, and an increasing contribution from the replacement cycle, could lead to further growth for the company. Additionally, the company's strong cash position, healthy gross margins, and profitability make it an attractive investment opportunity. With potential downside risks, such as competition and changes in reimbursement, our analysis suggests a positive outlook for Inspire Medical Systems.
Bears say
Inspire Medical Systems is facing risks to its target price, including reimbursement and coding changes, long-term impacts of competing pharmaceutical solutions, and lower-than-expected adoption of its Inspire therapy. Adjusted estimates for 2027 have been decreased, and the company is facing confusion and fogginess around reimbursement and coding. While their recently launched Inspire V device offers potential, it is still facing headwinds in terms of inventory dynamics and patient warehousing, and faces stiff competition from other medical solutions in the market.
This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.
INSP Analyst Forecast & Price Prediction
Start investing in INSP
Order type
Buy in
Order amount
Est. shares
0 shares